Back
Altamira Therapeutics Ltd. 10K Form
Sell
19
CYTOF
Altamira Therapeutics Ltd.
Last Price:
$0.08
Seasonality Move:
-11.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CYTOF News And Ratings
See the #1 stock for the next 7 days that we like better than CYTOF
CYTOF Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.37 |
| Price / Book: | 0.08 |
Profitability
| EPS (TTM): | -1.19000 |
|---|---|
| Net Income (TTM): | $-5.7M |
| Gross Margin: | $-127.1K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Altamira Therapeutics Ltd. Earnings Forecast
Key Altamira Therapeutics Ltd. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 8 years.
Altamira Therapeutics Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CYTOF |
| Website: | altamiratherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CYTOF Technical Analysis vs Fundamental Analysis
Sell
19
Altamira Therapeutics Ltd. (CYTOF)
is a Sell
Is Altamira Therapeutics Ltd. a Buy or a Sell?
-
Altamira Therapeutics Ltd. stock is rated a SellThe current Altamira Therapeutics Ltd. [CYTOF] share price is $0.07. The Score for CYTOF is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.